Creighton University receives NIH grant to address diabetes in adult American Indians

Creighton University School of Nursing has received a $207,000, two-year grant from the National Institutes of Health to address the growing problem of type 2 diabetes mellitus in adult American Indians.

Creighton principal investigator Marlene Wilken, R.N., Ph.D., will work with health care providers at the Omaha (Nebraska) and Rosebud Sioux (South Dakota) reservations to determine whether Talking Circles - a powerful American Indian tradition similar to many modern-day therapy groups- can help American Indians better self-manage and control their diabetes.

"We believe that using culturally appropriate Talking Circles will result in better adherence and outcomes for diabetes management by American Indians than diabetes education in a classroom setting," Wilken said.

For the study, all participants who meet the study criteria will be selected randomly. The experimental group will include 20 individuals from the Omaha Tribe who will receive the culturally appropriate Talking Circles intervention. Twenty participants from the Rosebud Sioux Tribe will serve as the control group and receive diabetes education in a regular classroom setting. This process will be repeated the second year.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
SGLT2 inhibitor canagliflozin shown to improve kidney oxygenation in diabetes patients